ANTCF (Aion Therapeutic) Net Margin %: -53.67% (As of Jan. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Aion Therapeutic Net Margin %?

Aion Therapeutic ANTCF Net Margin % is -53.67% as of Jan. 2025.

Net margin is calculated as Net Income divided by its Revenue. Aion Therapeutic's Net Income for the three months ended in Jan. 2025 was $-0.21 Mil. Aion Therapeutic's Revenue for the three months ended in Jan. 2025 was $0.38 Mil. Therefore, Aion Therapeutic's net margin for the quarter that ended in Jan. 2025 was -53.67%.

The historical rank and industry rank for Aion Therapeutic's Net Margin % or its related term are showing as below:


ANTCF's Net Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 5.145
* Ranked among companies with meaningful Net Margin % only.

Aion Therapeutic  (OTCPK:ANTCF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Aion Therapeutic Net Margin % Related Terms

Aion Therapeutic Net Margin % Historical Data

* Premium members only.

The historical data trend for Aion Therapeutic's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aion Therapeutic Net Margin % Chart

Aion Therapeutic Annual Data
Trend Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Net Margin %
Get a 7-Day Free Trial - - - - -1,710.90

Aion Therapeutic Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -170.22 -3,712.49 -85.27 -167.66 -53.67

ANTCF vs CBDY, GRPS, PLSH: Net Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Aion Therapeutic's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aion Therapeutic Net Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aion Therapeutic's Net Margin % distribution charts can be found below:

* The bar in red indicates where Aion Therapeutic's Net Margin % falls into.


Aion Therapeutic Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Aion Therapeutic's Net Margin for the fiscal year that ended in Apr. 2024 is calculated as

Net Margin=Net Income (A: Apr. 2024 )/Revenue (A: Apr. 2024 )
=-4.6560942688351/0.27214307710739
=-1,710.90 %

Aion Therapeutic's Net Margin for the quarter that ended in Jan. 2025 is calculated as

Net Margin=Net Income (Q: Jan. 2025 )/Revenue (Q: Jan. 2025 )
=-0.20587957532111/0.38364133827197
=-53.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -53.67% mean?
Aion Therapeutic (ANTCF) has a Net Margin % of -53.67% as of Jan. 2025. Net margin is the ratio of total net income to net sales. View historical data on Aion Therapeutic and its competitors.
Is Aion Therapeutic's Net Margin % too high?
Aion Therapeutic's current Net Margin % is -53.67%.
How does Aion Therapeutic's Net Margin % compare to CBDY and GRPS?
Aion Therapeutic's Net Margin % of -53.67% can be compared against companies in the Drug Manufacturers industry. The industry median Net Margin % is 5.15. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.15, based on 962 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Aion Therapeutic and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aion Therapeutic's current Net Margin % is -53.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aion Therapeutic stock overvalued right now?
Aion Therapeutic (ANTCF) has a current Net Margin % of -53.67%. The current Net Margin % is -53.67%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Aion Therapeutic (ANTCF), the current Net Margin % is -53.67% as of Jan. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aion Therapeutic Business Description

Address 700 West Georgia Street, Suite 2200, Vancouver, BC, CAN, V7Y 1K8
Aion Therapeutic Inc is in the business of research and development, treatment, data mining, and state of the art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals, and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery. During the year ended the Company had one operating segment, being health and wellness, dedicated to delivering state-of-the-art water filtration solutions. Geographically company earns revenue from USA.